Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688621's Dividend Payout Ratio is ranked better than 84.98% of 446
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs SHSE:688621: 0.13
During the past 9 years, the highest Trailing Annual Dividend Yield of Beijing Sun-Novo Pharmaceutical Research Co was 1.41%. The lowest was 0.21%. And the median was 0.34%.
During the past 12 months, Beijing Sun-Novo Pharmaceutical Research Co's average Dividends Per Share Growth Rate was -43.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -4.80% per year.
During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of Beijing Sun-Novo Pharmaceutical Research Co was -4.80% per year. The lowest was -4.80% per year. And the median was -4.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Beijing Sun-Novo Pharmaceutical Research Co Dividend Payout Ratio Related Terms
Beijing Sun-Novo Pharmaceutical Research Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Sun-Novo Pharmaceutical Research Co Dividend Payout Ratio Chart
Beijing Sun-Novo Pharmaceutical Research Co Annual Data
SHSE:688621 vs ZTS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Sun-Novo Pharmaceutical Research Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Sun-Novo Pharmaceutical Research Co Dividend Payout Ratio vs Drug Manufacturers Industry
Beijing Sun-Novo Pharmaceutical Research Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) has a Dividend Payout Ratio of 2.10 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Beijing Sun-Novo Pharmaceutical Research Co and its competitors. This is 1515% above median its historical median of 0.13. Over the past decade, Beijing Sun-Novo Pharmaceutical Research Co's Dividend Payout Ratio has ranged from 0.09 to 0.37. According to the industry distribution chart, Beijing Sun-Novo Pharmaceutical Research Co ranks #67 out of 446 companies in the Drug Manufacturers industry, placing it in the top 15%.
Is Beijing Sun-Novo Pharmaceutical Research Co's Dividend Payout Ratio too high?
Beijing Sun-Novo Pharmaceutical Research Co's current Dividend Payout Ratio of 2.10 is 1515% above median its 10-year median of 0.13. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.37. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Beijing Sun-Novo Pharmaceutical Research Co's value of 2.10 is 452.6% above this industry median. Based on the distribution chart, Beijing Sun-Novo Pharmaceutical Research Co ranks #67 out of 446 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Sun-Novo Pharmaceutical Research Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Sun-Novo Pharmaceutical Research Co's Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Beijing Sun-Novo Pharmaceutical Research Co ranks #67 out of 446 companies for Dividend Payout Ratio. This places Beijing Sun-Novo Pharmaceutical Research Co in the top 15% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Beijing Sun-Novo Pharmaceutical Research Co's value of 2.10 is 452.6% above this benchmark. Historically, Beijing Sun-Novo Pharmaceutical Research Co's own Dividend Payout Ratio has ranged from 0.09 to 0.37 over the past decade. While the company's 10-year median is 0.13 vs. the industry median of 0.38, Beijing Sun-Novo Pharmaceutical Research Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 446 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Sun-Novo Pharmaceutical Research Co's current Dividend Payout Ratio of 2.10 is 452.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Beijing Sun-Novo Pharmaceutical Research Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Sun-Novo Pharmaceutical Research Co's current Dividend Payout Ratio is 2.10, which is 1515% above median its own 10-year median of 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Sun-Novo Pharmaceutical Research Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) is currently considered Fairly Valued. The stock's GF Value™ is ¥65.02, compared to a current price of ¥70.65 — trading 8.7% above its estimated fair value. The current Dividend Payout Ratio is 2.10, which is 1515% above median its 10-year median of 0.13 and 452.6% above the Drug Manufacturers industry median of 0.38. Beijing Sun-Novo Pharmaceutical Research Co's overall GF Score™ is 92/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621), the current Dividend Payout Ratio is 2.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Sun-Novo Pharmaceutical Research Co stock appears to be overvalued.
The current stock price of ¥70.65 is trading 8.7% above its estimated GF Value™ of ¥65.02.
GuruFocus considers Beijing Sun-Novo Pharmaceutical Research Co to be Fairly Valued.
Key valuation signals for SHSE:688621:
Dividend Payout Ratio: 2.10 (1515% above median its 10-year median of 0.13)
GF Value™: ¥65.02 vs. price of ¥70.65 (8.7% above fair value)
Industry Position: 452.6% above the Drug Manufacturers median (#67 of 446)
No single metric tells the full story. See the SHSE:688621 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Sun-Novo Pharmaceutical Research Co Ltd is engaged in providing professional research and development outsourcing services for pharmaceutical companies.
92GF Score
Get the complete analysis for SHSE:688621
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688621 has been successfully added to your 
